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Abstract 
Asthma represents the leading cause of
morbidity from a chronic disease among chil-
dren. Dealing with this disease during the
perioperative period of pediatric surgical pro-
cedures is, therefore, quite common for the
anesthesiologist and other professionalities
involved. Preoperative assessment has a key
role in detecting children at increased risk of
perioperative respiratory complications. For
children without an optimal control of symp-
toms or with a recent respiratory tract infec-
tion elective surgery should be postponed, if
possible, after the optimization of therapy.
According to clinical setting, loco-regional
anesthesia represents the desirable option
since it allows to avoid airway instrumenta-
tion. Airway management goals are preventing
the increase of airflow resistance during gen-
eral anesthesia along with avoiding triggers of
bronchospasm. When their use is possible,
face mask ventilation and laringeal mask are
considered more reliable than tracheal intuba-
tion for children with asthma. Sevoflurane is
the most commonly used anesthetic for induc-
tion and manteinance. Salbutamol seems to be
useful in preventing airflow resistance rise
after endotracheal intubation. Mechanical ven-
tilation should be tailored according to patho-
physiology of asthma: an adequate expiratory
time should be setted in order to avoid a posi-
tive end-expiratory pressure due to expiratory
airflow obstruction. Pain should be prevented
and promptly controlled with a loco-regional
anesthesia technique when it is possible.
Potential allergic reactions to drugs or latex
should always be considered during the whole
perioperative period. Creating a serene atmos-
phere should be adopted as an important com-
ponent of interventions in order to guarantee
the best care to the asthmatic child.
Introduction
Asthma is one of the most common chronic
disease, affecting 300 million people world-
wide, with an increasing prevalence especially
among children.1 In childhood it represents
the leading cause of morbidity from a chronic
disease.
Several host and environmental factors
influencing the development of asthma have
been identified. Sensitization to aeroallergens,
maternal diet during pregnancy and/or lacta-
tion, tobacco smoke, infections and psychoso-
cial elements are the main environmental fac-
tors identified. However no intervention has
yet been proven to prevent the onset of asthma
or to modify its long-term natural course.2
Asthma is a chronic inflammatory disorder
of the airway characterized by airway hyperre-
sponsiveness associated with recurrent
episodes of wheezing, breathlessness, chest
tightness and coughing. The widespread but
variable airflow obstruction is often reversible
either spontaneously or with treatment.1 In
younger children, however, symptoms could be
less specific.2
The improvements of medical care have
decreased morbidity and mortality and the
incidence of perioperative severe complica-
tions in asthmatic children undergoing anes-
thesia and surgery. Nevertheless bron-
chospasm can still represent a lifethreatening
complication3 and an accurate attention for
details is necessary during the whole perioper-
ative  care to prevent the most severe adverse
events. The goals of the anaesthesiologic
management of the patient with asthma are to
prevent the potentially catastrophic event of
intraoperative bronchospasm4 and to tailor an
anaesthetic plan to the child in order to ensure
an adequate airflow, avoiding drugs and tech-
niques associated with a potential risk of
increasing pulmonary resistance.
The aim of this review is to focus on the
most debated topics of the anesthesiologic
management of the child with asthma trying to
clarify the latest observations.
Pathophysiology and clinicalconsiderations
Airway inflammation is the key feature of
asthma. It characterizes patients of all ages
and it is permanent even if symptoms are
episodic.1 The correlation between inflamma-
tion and airway hyperresponsiveness has been
established, but the mechanisms involved are
not completely clear. Airway hyperresponsive-
ness contributes to airway narrowing and air-
flow obstruction through several (incompletely
understood) mechanisms like changes in
smooth muscle contractility or sensory nerve
and autonomic activity.5,6
Several triggers of airway obstruction and
symptoms  have been identified in childhood:
infections, cold air, outdoor air pollution,
laughing, crying, activity.2 
Inflammatory edema and mucous plugging
contribute to airway narrowing by luminal
obstruction.3
Chronic inflammation is associated with
complex structural changes of the airway col-
lectively named airway remodeling. These fac-
tors progressively impair response to bron-
chodilator therapy.7,8
The following diagram3,5-10 (Figure 1)
underlines the pathophysiology sequence that
occurs in the patient with airway obstruction.
Some of the events described are the conse-
quence of a chronic disease (e.g. airway
remodeling)7,8 but a severe airway obstruction
and the related cardiac response may repre-
sent the expression of an acute perioperative
respiratory complication (bronchospasm)3 in a
patient with asthma (previous known or not).
Air trapping due to decreased airflow (espe-
cially during expiration) leads to dynamic
hyperinflation (with increasing positive end-
expiratory pressure, PEEP) and dynamic com-
pliance reduction of the lungs.3,9 Accessory
muscles recruitment is necessary to ensure a
normal tidal volume and to perform an active
exhalation in the presence of a severe airflow
obstruction:3 an increased work of breathing
and oxygen consumption is the consequence.9
With air trapping and muscle fatigue develop-
ment, CO2 retention increases and it repre-
sents the sign of decompensation and of a
need of immediate ventilatory support. The
increasing lung volume and PEEP may lead to
a decreased venous return to the heart and
hence to systemic hypotension and low perfu-
sion.3,9 Hypoxic pulmonary vasoconstriction
involves hypoinflated areas of the lung and
ventilation/perfusion ratio (V'/Q') mismatch
could be balanced at the beginning. However
the increased pulmonary vasculature resist-
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ance is responsible of the right ventricular
overload and further oxygen consumption.
Hypoxaemia represents the end stage of this
sequence and it is the result of the increasing
V'/Q' mismatch (due, among other factors, to
vasodilation run by inflammation).10
Preoperative assessment andrisk factors evaluationHistory
Uncontrolled baseline bronchial hyperreac-
tivity represents the most important risk factor
for perioperative adverse respiratory events in
asthmatic patients.11 A correct preoperative
history can intercept patients with inadequate
control of asthma.12 Information can be
obtained from child or parents, preferably both.
A history of a recent flare of the disease
requiring oral corticosteroids, an increased
use of inhaled short-acting β2-agonists, a
recent exacerbation of asthma symptoms, the
occurrence of emergency room or hospital visit
during the last months suggest a poorly con-
trolled disease.4,11 According to clinical condi-
tions of the child, elective surgery should be
cancelled and rescheduled after the optimiza-
tion of therapy. However anesthesia may be
required in children not responding to treat-
ment of severe symptoms of asthma exacerba-
tion or during urgent diagnostic/therapeutic
procedures such as bronchoscopy.
The use of systemic corticosteroids for more
than 2 weeks  within the prior 6 months should
also be sought in order to plan a perioperative
steroid therapy for the patients at risk for an
adrenal crisis.1,3,13,14 A history of at least two
family members having asthma, atopy, or
smoking increases the risk for perioperative
respiratory adverse events.15 A personal histo-
ry of eczema has been also considered signifi-
cant in this sense.15
Information about other possible risks or
complicating factors, like recent infections in
upper or lower respiratory tract, history of peri-
operative bronchospasm or previous pul-
monary complications during general anesthe-
sia,12 obesity, or environmental tobacco expo-
sure should be taken in consideration.
Previous allergic reactions should be inves-
tigated.16 In a prospective survey, latex was the
main cause of perioperative anaphylactic reac-
tions in children (76%).17-19 History is the
main tool to investigate a latex sensitivity.
Children submitted to multiple surgical proce-
dures, such as for spina bifida, especially at a
very young age, are at an increased risk of
latex sensitization. It could be useful to ask
specifically to parents and children whether
contact with rubber toys (e.g. ballons) or rub-
ber dam are responsible of lips and tongue
swelling, itching, rash or angioedema.19,20
Asking for allergy to some fruits (e.g. avocado,
banana, kiwi, chestnut) and vegetables (e.g.
tomato,  bell pepper, carrot) has been suggest-
ed to be helpful to detect an increased risk of
latex sensitivity since there is evidence of
cross-sensitivity between several shared anti-
gens.19
Concerning upper respiratory tract infec-
tions, fever, moist cough and green runny nose
are important elements to consider during the
preoperative evaluation.15 The higher inci-
dence of respiratory adverse events in children
with a present or recent respiratory tract infec-
tion21 might be explained by an increased air-
way sensitivity provoked by the underlying
inflammation and its influence on the auto-
nomic nervous system.6,22 This condition per-
sists after resolution of signs and symptoms
for a variable period and rescheduling an elec-
tive procedure 2-3 weeks after the upper respi-
ratory tract infection, when possible, is consid-
ered a safe approach.15 However this last deci-
sion should be made on a case by case basis,
after a risk-benefit ratio assessment including
the child's presenting symptoms and the
urgency and type of surgery. Frequency of res-
piratory infections should also be considered,
since a child could experience six to eight
episodes per year and it may be difficult to pre-
dict a symtoms free period for elective surgery.
Nevertheless, even before a non elective sur-
gery, the knowledge of a recent or active respi-
ratory infection could alert the anesthesiolo-
gist to the potential of complication and the
anesthetic management could be modified in
order to reduce any risk (e.g. avoiding airway
instrumentation if possible).22
Obese children have a significantly higher
prevalence of coexisting conditions, including
asthma.23
Tait et al.24 have identified obesity as an
independent predictor of perioperative critical
adverse events in children. El-Metainy et al.25
have observed a significant association
between obesity and asthma and a higher
occurrence of perioperative bronchospasm in
obese children, especially  with coexisting
asthma. An association between obesity and
quality of control was also identified for all
ages.1 Lung mechanics alterations, pro-inflam-
matory state and genetic, hormonal or neuro-
genic factors are some of the proposed mecha-
nisms that could influence the development of
asthma and its clinical course in the obese
patient.26,27 Environmental tobacco smoke
exposure increases the incidence and severity
of asthma and respiratory illness. Several stud-
ies have demonstrated that environmental
tobacco smoke exposure is an independent
predictor of adverse respiratory events in chil-
dren receiving general anesthesia28 and of
laryngospasm at the emergence from anesthe-
sia,29 especially in girls and in children whose
mothers had a lower educational level and
were exposed to maternal smoke.30
Review
Figure 1. Pathophysiology of airway obstruction. 
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Physical examination
Physical examination is usually negative
between exacerbations.3 Wheezing should be
detected on auscultation and accessory mus-
cles recruitment should be sought. Signs or
symtoms of respiratory infections should be
detected and decision about suitability for sur-
gery should be made after a complete evalua-
tion of the current clinical condition.15,22Functional tests
Spirometric evaluation could be important
in individuals suffering from severe bron-
chospasm or with uncertain anamnestic
data.11 However patient compliance in the
pediatric population should be considered and
could represent the main limit to the applica-
tion of functional tests.
Functional tests could be particularly useful
to assess bronchodilation response to therapy
in children as they could be unaware of signif-
icant changes of lung function and symptoms
could not be easily adopted to assess potential
optimization of respiratory function.31
Forced Expiratory Volume in the 1st second
(FEV1) has been included as one of the param-
eters estimating the level of asthma control. A
normal FEV1 is associated with a well con-
trolled disease whereas a FEV1<80% of pre-
dicted value or of the personal best (if known)
express a partly or not controlled disease.1 As
FEV1 requires a high grade of cooperation of
the child to obtain a valid estimation, its feasi-
bility is limited to children above the age of 5
years.31 Moreover, though functional tests may
improve the evaluation of impairment of respi-
ratory function, they don't quantify periopera-
tive respiratory risks:31 younger patients may
have a high level of bronchial hyperreactivity
without any spirometric parameters abnormal-
ities, implying a potential risk of underestima-
tion.12
Concerning respiratory function modifica-
tion during general anesthesia, well controlled
asthmatic children exhibit a decrease in FEV1
and Peak Expiratory Flow (PEF); anyway the
decrease appears to be similar to the one
observed in healthy children.32Lab tests
Eosinophilic cationic protein (ECP) is a
marker of eosinophil activation; ECP measure-
ment was proposed as an index of  severity of
the disease and of compliance to regular treat-
ment. Scalfaro et al.33 have measured ECP lev-
els in serum to find any possible correlation
between severity of the disease and respirato-
ry resistance (Rrs) increase after intubation;
nevertheless they have not found any correla-
tion between either asthma history or serum
ECP level and Rrs response to endotracheal
intubation.33 Von Ungern-Sternberg et al.34
have observed a significant correlation
between ECP levels in BAL fluids of children
undergoing general anesthesia and the degree
of airway instability and thus of perioperative
bronchospasm. Further investigations are nec-
essary before the feasibility of these observa-
tions in the clinical setting.
Systematic preoperative screening for latex
allergy is not advisable since a high percentage
of population is sensitized to latex antigens
(approximately 7-8%, detected by latex specific
IgE).20,35
Therefore high risk children should be iden-
tified through history19,20 and allergic tests
should be performed only in this group of
patients.36 If the clinical history concerning
allergies is positive or equivocal, the patient
should be referred to an experienced allergolo-
gist to perform preoperative tests.20 According
to the local availability, either a blood test for
specific IgE or skin testing could be per-
formed.20
Intraoperative ManagementPremedication
Since it is recognized that the psychological
component of asthma in the child may influ-
ence the clinical course and the recurrence of
acute attacks,1,2 it is important to guarantee a
serene atmosphere and to avoid as much as
possible all potential stressful events.
According to our experience, allowing the pres-
ence of a selected37 and prepared parent in the
operating room, until the induction of anesthe-
sia, is a simple but important element in order
to avoid child anxiety. It represents a compo-
nent of a novel, multimodal, family-centered
approach that should be applied in the periop-
erative care of the child.38,39
A premedication with midazolam could be
necessary when anxiety (with the consequent
hyperventilation) is not well controlled;40 the
choice of the route of administration is one of
the key point; rectal and oral administrations
appear to be the least invasive ways; inhala-
tional administration may be a valid alterna-
tive, but its potentially irritating effects make
it a not recommended route in asthmatic
patients. The use of oral midazolam 0.5 mg/kg
has been proved safe in the asthmatic child;41
in our experience the administration of rectal
midazolam 0.6 mg/kg is safe and well tolerated
too, especially in younger children.
It is important to continue the usual inhala-
tional therapy until the day of surgery.14 The
use of inhaled β2 agonists (salbutamol) prior
to the theater is useful to prevent the respira-
tory resistance increase observed after endo-
tracheal intubation under sevoflurane in midly
to moderate asthmatic children.33
Premedication with corticosteroid or anti-
histaminic drugs does not guarantee that an
anaphylactic reaction will not occur and its
extensively use in atopic children appears not
to be justified.16Induction and mantainanceAirway
Airway instrumentation represents a well
known trigger of bronchospasm.3 The direct
mechanical stimulation of airway that occurs
during endotracheal intubation could be
responsible for a parasympathetic mediated
reflex27 and for the release of substance P and
neurokinine A as a consequence of fibers C
stimulation.42 An increased risk for respiratory
adverse events in the child has been observed
with a failure on airway securing and when
more attempts of airway securing were
requested. According to these observations,
the use of face mask or laryngeal mask in the
child with asthma is considered more reliable
than tracheal intubation.15,43 However when
bronchospasm (or obviously laryngospasm)
occurs, endotracheal intubation seems to be a
more reliable method of airway securing
according to our experience.
The use of lidocaine in order to prevent
bronchospam following airway instrumenta-
tion and Rrs increase after tracheal intubation
is controversial. Its irritating effect has been
supposed to be responsible for the observed
bronchospasm after lidocaine inhalation, espe-
cially in patients with airway hyperresponsive-
ness.44 Intravenous (IV) lidocaine administra-
tion shows a benefit in some but not all stud-
ies enrolling anesthetized humans.45-49 A cen-
tral nervous system involving mechanism has
been proposed to explain the possible IV lido-
caine benefit.47 An airway narrowing was
observed after IV lidocaine in non anesthetized
asthmatic subjects without airway stimulation
and it has been supposed that baseline
increasing airway tone after IV lidocaine could
explain its inconstant beneficial effect after
tracheal intubation.47 However a case of a
severe bronchospasm occurring in an asthmat-
ic child has been recently reported and repeat-
ed airway auscultation has been  recommend-
ed after IV lidocaine use.49
When endotracheal intubation is performed,
the use of uncuffed endotracheal tubes
appears to be the first choice option in chil-
dren, especially in smaller ones; anatomical
features and an appropriate tube size ensure
an adequate sealing.50-53 The presence of asth-
ma may represents a further indication to
uncuffed tube usage. When a cuffed endotra-
cheal tube is required (e.g. head-neck surgery,
neurosurgery, laparoscopic surgery) a perfect
timing of extubation is essential; indeed cuff
deflating could represent a further irritating
factor. In order to avoid airway reflexes, extu-
bation could be performed when the child is
deep but with a spontaneous and valid respira-
tory activity.22 However awake extubation is
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necessary for some surgical interventions (e.g.
craniofacial surgery), when intubation was
difficult, when there is concern for aspiration
of gastric content or according to hospital
organization.54
Concerning the use of laryngeal masks, clas-
sic pediatric size models are not provided of a
drainage tube55 and considering also the big-
ger size of the tongue in proportions to the
other anatomical structures, suction of airway
and gastric secretions before emergence could
not be feasible and bronchospasm triggering
by secretions should, therefore, be considered. 
Ventilation with face mask should be avoid-
ed when it is not possible to establish the com-
plete gastric emptying.Muscle relaxation
Among pediatric anesthesiologists, the prac-
tice of induction without muscle relaxant use
is common.46,56,57 According to our experience,
intubation is usually performed under deep
inhalation anesthesia and muscle relaxation
drugs are not necessary during the majority of
ambulatory and minor surgical procedures,
especially for younger children. Avoidance of
these drugs when not necessary reduces the
side effects related to their mechanism of
action (muscarinic agonism and histamine
release), the incidence of allergic reactions
and the adverse effects due to reversal drugs
using.58 However muscle relaxation may be
useful for certain surgical procedures to
improve operative conditions (e.g. major
abdominal operations). For this purpose, the
use of vecuronium and cisatracurium is con-
sidered safe in the asthmatic patient according
to their lower affinity to M2 muscarinic recep-
tors and power of histamine release.4,59
Mivacurium has been identified as a trigger
of bronchospasm in asthmatic children accord-
ing to its histamine (and maybe other media-
tors) release capacity in a dose-dependent
manner.60
Atracurium in asthmatic patients should be
used with caution in dose and rate of adminis-
tration.4,61 The use of muscle relaxation rever-
sal drugs should be avoided since they
increase airway secretions and bronchial
hyperactivity.58 However complete reversal of
neuromuscular blockade should be carefully
verified in order to ensure an adequate postop-
erative ventilation. Sugammadex, a selective
neuro-muscle blockers binding agent, could be
used for a rapid muscle relaxation reversal,
avoiding the side effects of anticholinesterase
drugs,62,63 but further investigations are nec-
essary before its routinary use in the pediatric
and asthmatic population.Inhalational agents
Inhalational agents have been the anesthet-
ics of choice for patients with airway hyperre-
sponsiveness. Volatile agents have shown a
bronchodilatory effect, and a decrease in hista-
mine release from leukocytes has been
observed with their use.4
Desflurane is the only inhalational anes-
thetic not recommended in patients with air-
way hyperresponsiveness; it has been associ-
ated with coughing, laryngospasm, bron-
chospasm and an increase of secretions. The
increase in resistance and inertance in chil-
dren with airway hyperresponsiveness, more
susceptible to the irritative nature of desflu-
rane, appears to involve the peripheral airways
too.64
Sevoflurane is the most used volatile agent
for anesthesia in children. Habre et al.65 have
observed a small but significative increase of
Rrs after endotracheal intubation under
sevoflurane (1.2 MAC) in asthmatic children;
however a decrease in Rrs both in asthmatic
and in non asthmatic children has been
observed after an increase of sevoflurane con-
centration (1.7 MAC). Although the increase of
Rrs has been not associated with clinically sig-
nificant respiratory adverse events, caution
has been recommended for children with more
severe and unstable asthma.
The administration of inhaled β2-adrenergic
agonists before tracheal intubation under
sevoflurane appears to prevent the Rrs
increase. The same authors33 have investigat-
ed the use of salbutamol in mild to moderate
asthmatic children under sevoflurane, observ-
ing a protective effect in this group of patients.
However the prophylactic effect seems to be
incomplete, showing a decrease in the airway
resistance component but not in the parenchy-
mal one. 
Recently fentanyl has been studied in order
to detect a protective effect against respiratory
reflexes in children under sevoflurane:
Thomas et al.66 have found the same incidence
of laryngospasm in children anesthetized with
sevoflurane despite the administration of two
successive doses of 1.5 mcg/kg of fentanyl,
probably for the lower depressant action of opi-
oids on upper airway originating stimuli com-
pared to lower airway originating ones.
The incidence of laryngospasm seems to be
higher using sevoflurane than propofol unless
cough and expiratory reflexes have been
observed to be lower under  sevoflurane anes-
thesia, regardless of level of hypnosis.67Intravenous agents
Several studies have been conducted to eval-
uate the effects of intravenous agents on res-
piratory resistances. Using an animal model,
Brown et al.68 have observed a dose dependent
attenuation of vagal nerve stimulation-induced
bronchoconstrinction after the infusion of
propofol or ketamine. They supposed a local,
neurally mediated, mechanism. The same
authors have underlined the importance of the
preservative agents contained in some propo-
fol formulations (e.g. metabisulfite) in influ-
encing these observations.69
In a population of non asthmatic patients,
etomidate, propofol and thiopental have been
compared for their effect on respiratory resist-
ance after tracheal intubation, observing the
lowest Rrs increase after propofol induction.70
Recently a neurokinin A involving mechanism
has been observed in an animal model investi-
gating the tracheal smooth muscle contration
attenuation by propofol.71
There is concern about a higher risk of
adverse reactions to propofol in patients with a
sensitivity to some food (e.g. eggs, peanuts and
soybean oil).72 A possible anaphylaxis after
propofol administration in a child with several
food allergies (eggs and peanut oil), atopy and
reactive airway disease has been reported; the
authors suggest to avoid propofol in patients
with a documented allergy to these foods
whether it is possible.73 It is likely that the
manufacturing process of propofol removes or
denatures the proteins which are responsible
for egg and soya allergies. However a cautious
approach for these groups of patients has been
recently suggested.20 Use of propofol, there-
fore, should be evaluated after a risk-benefit
balance in the single child.20,74-76
Ketamine has been promoted in the past as
the intravenous anesthetic of choice for the
patient with asthma.14 Its bronchodilator effect
is related to the systemic catecholamine
increased level following its infusion and to a
direct interference with the parasympathetic
and endothelin pathways.3,77 The increase of
airway secretion represents a disadvantage of
its use in the asthmatic child when not associ-
ated with an anticholinergic drug.3,4 A big ran-
domized controlled trial involving asthmatic
children is necessary in order to justify its use
as a first choice intravenous agent.
Concerning the use of opioid analgesics,
histamine-release potential of morphine is
well known78 and its use in asthmatic patients
has been discouraged. Conversely, synthetic
opioids like fentanyl and remifentanyl have not
been associated with a significant histamine
release78 and therefore they have been used in
asthmatic patients. Despite their off-label con-
dition in pediatrics, their use is widespread
and experience with these drugs is growing.
Coughing after fantanyl and remifentanyl
intravenous administration has been reported
in adults and children79-82 and risk seems to be
higher in this last group;83 since coughing
could represent a trigger of bronchospasm in
asthmatic children, particular attention should
be paid during and after their use.Mechanical ventilation
Mechanical ventilation should be tailored to
the pathophysiologic changes observed in the
child with asthma. In order to prevent air trap-
ping due to increased expiratory resistances, a
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longer expiratory time should be assured and
thus an adeguate respiratory frequency rate
adopted. The aim of this strategy is to avoid
intrinsic positive end-expiratory pressure
(PEEP) and the subsequent events described
above.3,9,84
Plateau pressure (Pplat), which is the
expression of post-inspiratory alveolar pres-
sure, should be assessed and monitored in
order to prevent barotrauma.9,85-87
Inhaled gases should be properly warmed
and humidified,3 especially when a low flow
circuit is not used, since cold and dry air could
represent a trigger of bronchospasm.1Perioperative complications
Complications could be divided (Table 1)
into two big groups: complications due to air-
way management (bronchospasm, laryn-
gospasm, cough, oxygen desaturation, stri-
dor)15 and complications due to air trapping
(hypotension, pneumothorax, subcutaneous
emphysema, cardiac arrest).3,84,85 Even if not
specifically related to the pathophysiology of
asthma, anaphylaxis could be considered
among the possible complications of the child
with atopy and allergic asthma.14,19
The incidence of complications in asthmat-
ic patients appears to be low, according to
reported data. Warner et al.88 have found a fur-
ther low incidence of complications in chil-
dren (0,6% of perioperative respiratory com-
plications in patients aged <9 vs. 2.4% in
patients aged >9; laryingospasm was the only
complication observed in patients aged 0-9).
Tube malposition and tube occlusion
because of secretions are the first causes of
complications and they must be rapidly veri-
fied at the occurrence of signs suggesting a
possible adverse event.27 Intraoperative bron-
chospam is recognized by polyphonic, bilater-
al, expiratory wheeze, increased airway pres-
sure, endtidal CO2 rise and possibly hypox-
emia.
In awake child wheezing is associated with
prolonged expiration and accessory muscles
recruitment with increased respiratory effort.
In most severe cases respiratory silence repre-
sents the complete airflow arrest. The differ-
ential diagnosis, along with mucous plugging
and tube malposition (e.g. kinked, bronchial
intubation with unilateral wheezing) includes
pulmonary edema and tension pneumotorax.
The possibility of a foreing body obstruction
(e.g. a tooth) should also be considered.3,27
Broncho spasm should be promptly treated
since development of hypoxia is responsible
for serious and early injuries in children.
100% oxigen shoud be administered and anes-
thesia deepened (raising the concentration of
inhalational anesthetics). Manual bag ventila-
tion could be useful to asses compliance of the
thoraco-pulmonary system and to achieve a
rapid inspiratory flow to facilitate a longer
expiratory time.3,27 A rapid-acting β2 agonist
should be administered via a nebulizer (2.5-5
mg every 20-30 min).14 Corticosteroid therapy
is usually administered even if it does not rep-
resent a first line therapy of bronchospam (4
mg/Kg hydrocortisone e.v.).14,27,89 Magnesium
sulfate ev, a drug proposed for status asthmati-
cus, has been included as a second line treat-
ment for persistent bronchospasm (40 mg/Kg
over 20 min).3,9,14 For refractory bron-
chospasm or when an anaphylactic reaction is
suspected, epinephrine use should be prompt-
ly considered (1-10 mcg/Kg, depending on the
severity of bronchospasm and patient's
respon se).19,89,90
The incidence of perioperative anaphylax-
is in children is 1:7,700 and latex represents
the main substance involved in this popula-
tion (76% of reactions).17,18 It has been
reported that a history of atopy is associated
with an up to 10-fold increase of latex sensiv-
ity.19 As mentioned above (see History), chil-
dren at increased risk of latex sensitivity are
those who have undergone multiple surger-
ies (especially in early life, e.g for congenital
urologic, gastrointestinal and tracheoe-
sophageal defects) as well as children with
spina bifida.19
Intraoperative allergic reactions have a
broad spectrum of manifestations depending
on trigger agent, its route and rate of adminis-
tration, the nature of the patient's hypersensi-
tivity, the state of health of the patient and the
effects of concomitant medications (e.g. anti-
histaminic drugs, β blockers).20 The clinical
features usually develop within few minutes
but may be delayed by up to an hour.20
Distinction between the allergic nature of a
reaction and a non-immunologic adverse
event, such a direct non-specific hystamine
release, could be impossible on a clinical
basis. However clinical manifestations seem
to be more severe when they occur during an
allergic anaphylaxis.18,20 Clinical features of
an anaphylactic reaction include hypotension,
tachycardia or bradycardia, bronchospasm and
hypoxia, cutaneous manifestations such as
flushing, erythema, rash or urticaria,
angioedema and cardiac arrest.19,20 In patients
with pre-existing asthma, bronchospam could
be more common.20 Cutaneous manifestations
may be more likely observed during non-aller-
gic anaphylaxis or may be masked by surgical
drapes during an allergic anaphylaxis.18,19
When a single clinical sign represents the
presentation of anaphylaxis, it could easily be
misdiagnosed since other causes related to
anesthesia are commonly sought. Considering
anaphylaxis as the cause of an intraoperative
adverse event such as hypotension or bron-
chospam, unless there exists a more likely
cause, could represent an advisable approach,
especially in high risk patients.19,20,89
When a trigger substance is suspected it
should be promptly removed.19,89 Cardiova -
scular instability could be treated with intra-
venous boluses of balanced salt solution (20
mL/Kg during 10-20 min) and Trendelenburg
position.19 Balanced salt solutions containing
sodium metabisulfite as stabilizer should be
avoided since thay could provoke bron-
chospam in asthmatic patients.91 According to
the severity of bronchospasm and hypoten-
sion, intravenous epinephrine should be asso-
ciated to fluid resuscitation (from 1-10
mcg/Kg).19 After stabilization of clinical condi-
tion, the allergic nature of the reaction should
be confirmed along with the responsibility of
the suspected agent in order to provide precise
recommendations for future anesthetic proce-
dures. A detailed description of the reaction,
its time of onset and its relation with drugs
administration and other events should be
provided by the anesthesiologist to the spe-
cialist centre to which the patient should be
referred. Blood samples should be taken as
soon as possible after the stabilization of the
clinical condition, 1-2 hours after the onset of
the event and at 24 h or during convalescence:
these samples are useful for mast cell tryptase
level determination, a commonly used marker
of mast cell degranulation. Skin tests for the
suspected agent and specific IgE determina-
tion, according to local availability, are the
other tests which should be performed in the
allergology centre.19,20
Suppression of hypothalamic-pituitary-
adrenal axis may be present after a steroid
therapy and thus an adrenal crisis may be pre-
cipitated by the surgical stress.14 Such possi-
bility should be considered particularly in chil-
dren requiring high doses of systemic corti-
costeroids to control asthma, but also in chil-
dren using high doses of inhaled corticos-
teroids.92,93 Intrave nous hydrocortisone and
fluid resuscitation are the key point of therapy
for the adrenal crisis, along with treatment of
hypoglicemia.14
Review
Table 1. Classification of perioperative
complications of the child with asthma.
Complications related to airway management
Bronchospasm
Laryngospasm
Cough
Oxygen desaturation
Stridor
Complications related to air trapping
Hypotension
Pneumothorax
Subcutaneous emphysema
Cardiac arrest
Others
Anaphylaxis
Adrenal crisis
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Postoperative Care
The control of post-operative pain has a key
role in the post-operative management of the
child;94 furthermore in the asthmatic child
uncontrolled pain could induce a stressful
state and provoke bronchospasm and other
complications. Pain should be prevented or
rapidly controlled;94 the use of non-pharmaco-
logical strategies may have positive effects and
contribute to create a relaxing environment
around the child and his family.38
A local/regional anesthesia technique
should be always chosen unless there are
important contraindications not to.94 When a
systemic analgesia is required, acetamino-
phen (paracetamol) is the first choice drug to
treat mild to moderate post-operative pain in
children.95 Acetaminophen has been associat-
ed to bronchospasm and wheezing, especially
in patients with aspirin-sensitivity history;1,96
glutathione depletion in the respiratory tract
or trigger action of some additives have been
suggested as possible mechanisms.96,97 How -
ever the association between reported reac-
tions to paracetamol and a real hypersensitivi-
ty to this drug appears to be weak in most
cases, and thus paracetamol remains a valid
alternative to non-steroid anti-inflammatory
drugs (NSAIDs) in asthmatic patients.96,98
Anyway many asthmatic children can take
NSAIDs without reactions; it could be useful to
check any past exposure and reactions to
NSAIDs.1,94 Because of the association
between aspirin and Reye syndrome, aspirin is
today rarely administered to children and
aspirin sensitivity could be not recognized in
young children with asthma. Aspirin-induced
asthma is probably underestimate in chil-
dren;97 aspirin hypersensitivity seems to be
present in about 2% of children,94 but this per-
centage increases when children undergo an
oral provocation test.
It has been suggested that NSAIDs like
ibuprofen could offer a protective effect when
used in acute scenarios (e.g. post-operative
pain) because of the antinflammatory activity
on the airway inflammation, known as one of
the main features of pathogenesis of asthma.97
Despite diclofenac has been proven safe in
children with asthma in some studies, authors
of a recently published Cochrane review have
concluded that further investigation are
required to definitely asses its optimal dosing
and safety.99
Conclusions
Asthma is a very common disease, with
increasing trends especially in children2 and
all professionalities involved in the pediatric
setting have to handle with it.
The correct evaluation of the baseline dis-
ease is the key point of preoperative assess-
ment;1,4,11 every possible risk factor for respira-
tory complications must be taken into consid-
eration,15 corrected if possible or suggest to
reschedule surgery if elective and whether this
is feasible based on clinical conditions of the
child. According to the clinical setting, locore-
gional anesthesia should be always considered
as the fist choice for the child with asthma.14
Airway should be carefully managed and
inhalational anesthesia appears to be the best
option in the asthmatic child under general
anesthesia. Perioperative complications
should be promptly recognized and treat-
ed.19,88-93 An adequate post-operative pain con-
trol may reduce the risk of complications and
improve the outcome of the patient.94 A proper
perioperative management of the child with
asthma has a key role for an uneventful anes-
thesia with a sufficiently low risk of serious
complications. 
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